What is the generic name?

ELAPEGADEMASE-LVLR

What is the Trade Name for ELAPEGADEMASE-LVLR?

Revcovi

What are the Indications for ELAPEGADEMASE-LVLR?

• 1 INDICATIONS AND USAGE REVCOVI is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. REVCOVI is a recombinant adenosine deaminase indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. ( 1 )

References: https://open.fda.gov/